2938, 2862, 1772 and 1717; δH(CDCl3) 3.02 (1H, dq, J 6.9, 6.9),
2.79 (1H, dd, J 14.9, 2.0), 2.54 (1H, ddd, J 15.4, 2.5, 2.5), 2.35
(1H, d, J 14.9), 1.13 (3H, d, J 7.2) and 1.00 (3H, d, J 6.5);
HREIMS m/z (rel. int %) 236.1412 (Mϩ, ∆ = 0.3 mmu for
C14H20O3) (93), 208 (100), 180 (75), 179 (72), 163 (67) and 134
(35).
NaBH4 reduction of 13
Compound 13 was reduced under similar conditions to those
employed with compound 14 to yield 16 as an oil, [α]D Ϫ14.6 (c
0.58 in CHCl3); νmax/cmϪ1 (CHCl3) 3502br, 2924, 2854 and 1720;
δH(CDCl3) 3.66 (3H, s, OMe), 3.59 (1H, dddd, J 11.7, 11.7, 4.9,
4.9, H-4), 2.30 (1H, dq, J 11.1, 6.8, H-11), 1.10 (3H, d, J 6.9,
H-13) and 0.83 (3H, d, J 6.2, H-14); δC(CDCl3) 177.7 (C, C-12),
71.8 (CH, C-4), 51.4 (CH3, OMe), 43.7 (CH, C-7), 42.9 (CH,
C-1), 42.3 (CH, C-11), 36.0 (CH, C-6), 35.6 (CH2, C-9), 30.4
(CH2, C-3), 30.1 (CH2, C-5), 27.4 (CH, C-10), 26.5 (CH2, C-8),
26.3 (CH2, C-2), 19.6 (CH3, C-14) and 15.0 (CH3, C-13);
HREIMS m/z (rel. int %) 254.1888 [Mϩ, ∆ = Ϫ0.6 mmu for
C15H26O3] (1), 236 (2), 205 (1), 177 (2), 149 (100), 121 (2), 107 (3),
93 (3) and 88 (52).
Conversion of 8 into the free acid 17
Compound 8 (9.0 g) was dissolved in aqueous KOH (10% w/v;
180 ml), after which sufficient aq. HCl (3 ) was added to the
solution to bring it to pH ca. 3. The resulting solid was filtered
off, washed with a small amount of ice-cold water and then
subjected to suction to dry it. Compound 17 as a white solid
(4.5 g) resulted; δH(CDCl3) 5.93 (1H, s), 2.75 (1H, dq, J 11.2,
6.8), 2.52 (1H, dd, J 11.1, 3.3), 2.37 (1H, ddd, J 15.0, 4.0, 4.0),
1.22 (3H, d, J 6.7) and 1.02 (3H, d, J 5.9); HREIMS m/z (rel.
int %) 236.1409 [Mϩ, ∆ = 0.3 mmu for C14H22O3] (93), 208 (100),
180 (75), 179 (72), 163 (67) and 134 (35).
Preparation of the cyclohexane dione 12 from isopulegol
A solution of (Ϫ)-isopulegol (8.0 g) in acetone (30 ml) was
cooled to 0–5 ЊC and to it was added cooled Jones oxidation
reagent at a rate sufficient to maintain the temperature of the
reaction mixture at ca. 20 ЊC. The reaction mixture was stirred
for a further 1.5 h, after which it was extracted with light petrol-
eum (bp 40–60 ЊC; 3 × 30 ml). The combined extracts were
washed successively with saturated brine (2 × 30 ml), saturated
aq. NaHCO3 (2 × 30 ml) and then again saturated brine (30
ml), after which they were dried (MgSO4) and evaporated under
reduced pressure to give 2-isopropenyl-5-methylcyclohexanone
(5.5 g) as an oil, [α]D Ϫ3.10 (c 3.8 CHCl3); νmax/cmϪ1 (CHCl3)
3079, 3024, 3013, 2930, 2872, 1703 and 1647; δH(CDCl3) 4.94
(1H, s), 4.72 (1H, s), 2.96 (1H, dd, J 12.9, 5.4), 2.41 (1H, ddd, J
13.0, 3.5, 2.2), 1.75 (3H, s) and 1.03 (3H, d, J 6.1); δC(CDCl3)
209.8 (C), 143.6 (C), 112.8 (CH2), 57.9 (CH), 50.7 (CH2), 35.3
(CH2), 34.0 (CH2), 31.3 (CH2), 22.3 (CH3) and 21.3 (CH3). A
solution of 2-isopropenyl-5-methylcyclohexanone (100 mg) in
THF (1 ml) was added dropwise to a solution of lithium diiso-
propylamine (LDA) in THF at Ϫ78 ЊC [prepared from BuLi
(1.6 ; 0.5 ml) diisopropylamine (0.5 ml) and THF (3 ml)].
After being stirred for 30 min, the mixture was treated with 3-
trimethylsilylbut-3-en-2-one14 (140 mg) in THF (1 ml), added
dropwise, after which stirring was continued at Ϫ78 ЊC for 1 h.
The reaction mixture was then allowed to warm to 0 ЊC (2.5 h)
after which it was acidified with 10% aq. HCl (pH ca. 3) and
stirred for a further 15 min. It was then neutralized with 5% aq.
NaHCO3 and extracted with EtOAc. The extract was washed,
dried and concentrated to give 12 as a crude product (55 mg).
This was purified by column chromatography (15% EtOAc–
hexane) to afford an oil, [α]D ϩ27.2 (c 1.6 in CHCl3); νmax/cmϪ1
(CHCl3); 2959, 2934, 2860 and 1708; δH(CDCl3) 4.92 (1H, s),
4.70 (1H, s), 3.00 (1H, d, J 13.0, 5.2), 2.58 (1H, ddd, J 17.2, 9.2,
5.4), 2.39 (1H, ddd, J 17.2, 9.1, 6.3), 2.12 (3H, s), 1.74 (3H, s)
and 1.10 (3H, d, J 5.9); HREIMS m/z (rel. int %) 222.1617 (Mϩ,
∆ = 0.3 mmu for C14H22O2) (85), 207 (20), 164 (70) and 109
(100).
Methylation of 11
To a mixture of 11 (0.20 g), MeOH (0.14 g) and 4-dimethyl-
aminopyridine (0.04 g) in CH2Cl2 (2 ml), was added a solution
of dicyclohexylcarbodiimide (DCC) in CH2Cl2 (1.446 ; 0.4
ml). After the mixture had been stirred overnight, a precipitate
formed which was filtered off. The filtrate was concentrated to
give 13 as a colourless liquid (0.08 g). This was purified by
preparative TLC (hexane–EtOAc, 7:3) to afford an oil, [α]D
ϩ4.9 (c 0.12 in CHCl3); νmax/cmϪ1 (CHCl3) 2955, 2855, 1732
and 1668; δH(CDCl3) 5.76 (1H, s), 3.69 (3H, s), 2.73 (1H, dq, J
8.5, 6.8), 1.22 (3H, d, J 6.8) and 1.04 (3H, d, J 5.9); HREIMS
m/z (rel. int %): 250.1570 [Mϩ, C15H22O3 ∆ = Ϫ0.1 mmu] (55),
191 (100) and 163 (95).
Methylation of 17
To a mixture of 17 (6.6 g) and Diazald (30.0 g) in MeOH (153
ml), was added dropwise a methanolic solution of KOH (7.8
g/241 ml) with ice–salt cooling. The reaction mixture was
stirred overnight at room temperature to afford a white preci-
pitate which was filtered off. The filtrate was concentrated to
give 14 as a pale yellow liquid (3.3 g). This was purified by
column chromatography (hexane–EtOAc, 16:9); δH(CDCl3)
5.76 (1H, s), 3.54 (3H, s), 2.82 (1H, dq, J 11.2, 6.8), 2.37 (1H,
ddd, J 15.9, 5.1, 4.0), 1.20 (3H, d, J 6.8) and 1.05 (3H, d, J 5.9);
HREIMS m/z (rel. int %) 250.1570 [Mϩ, ∆ = Ϫ0.1 mmu for
C15H22O3] (20), 191 (10), 163 (70) and 162 (100).
NaBH4 reduction of 14
A solution of 14 (575 mg) in pyridine (9 ml) was added to a
suspension of NaBH4 (504 mg) in pyridine (7 ml). The reaction
mixture was stirred at room temperature for 6 h, after which it
was acidified with aq. HCl (3 ) and then extracted with Et2O
(60 ml). The extract was washed with dil. aq. HCl and water,
dried (MgSO4), and concentrated to give 18 as an oily crude
product (200 mg). This was purified by column chrom-
atography (hexane–EtOAc, 7:3 v/v) to afford an oil, [α]D Ϫ63.9
(c 1.1 in CHCl3); νmax/cmϪ1 (CHCl3) 3503, 2924, 2854 and 1720;
δH(CDCl3) 4.19 (1H, br s, OH), 3.85 (1H, ddd, J 11.7, 6.0, 5.8,
H-4), 2.68 (1H, dd, J 6.3, 6.0, H-5), 2.28 (1H, dq, J 11.5, 7.2,
H-11), 2.08 (1H, m, H-3β), 1.61 (1H, ddd, J 13.4, 6.8, 3.6, H-
9β), 1.25 (1H, dddd, J 12.7, 12.7, 11.7, 3.6, H-3α), 1.09 (3H, d, J
7.2, H-13), 0.87 (3H, d, J 6.3, H-14), 0.83 (1H, dddd, J 12.8,
12.8, 12.8, 3.0, H-2β) and 0.55 (1H, dddd, J 11.4, 11.4, 11.4, 2.5,
H-1); δC(CDCl3) 225.3 (C, C-12), 70.2 (CH, C-4), 54.8 (CH,
C-5), 45.0 (CH, C-6), 44.5 (CH, C-11), 43.3 (CH, C-1), 42.8
(CH, C-7), 35.3 (CH, C-10), 34.5 (CH2, C-3), 31.7 (CH2, C-9),
26.0 (CH2, C-2), 25.0 (CH2, C-8), 19.3 (CH3, C-14) and 15.1
(CH3, C-13); HREIMS m/z (rel. int %) 222.1617 [Mϩ, ∆ = 0.2
mmu for C14H22O2] (28), 204 (60), 173 (40), 163 (50), 149 (100)
and 148 (98).
Robinson annulation of 12
To a solution of the diketone 12 (50 mg) in EtOH (4 ml) was
added Ba(OH)2ؒ8H2O. The mixture was stirred at room temper-
ature for 1.5 h and then neutralized with 10% aq. HCl and
concentrated under reduced pressure. The residue was extracted
with CH2Cl2 and the extract was washed, dried and evaporated
under reduced pressure. The crude product was purified by
HPLC (23% EtOAc–hexane) to give 21 (20 mg) (Rt 13.34 min)
and 20/22 as a mixture (5 mg) (Rt 13.07 min).
Compound 21. Oil, [α]D Ϫ205.4 (c 0.28 in CHCl3); νmax/cmϪ1
(CHCl3) 3011, 2961, 2930 and 2874; δH(CDCl3) 5.76 (1H, d,
J 2.0, H-5), 2.76 (1H, ddd, J 13.7, 3.7, 3.7, H-8), 2.42 (1H, m,
H-3), 1.83 (1H, ddd, J 12.8, 7.5, 3.7, H-9), 1.77 (3H, s, H-12),
1.76 (3H, s, H-13), 1.25 (1H, dddd, J 13.0, 13.0, 13.0, 3.9, H-9)
and 1.03 (3H, d, J 6.4, H-14); δC(CDCl3) 200.3 (C, C-4), 164.0
(C, C-6), 133.1 (C, C-7), 129.6 (C, C-11), 126.5 (CH, C-5), 45.4
(CH, C-1), 39.6 (CH, C-10), 36.4 (CH2, C-3), 34.7 (CH2, C-9),
J. Chem. Soc., Perkin Trans. 1, 1997
3441